ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
暂无分享,去创建一个
Iannis Aifantis | Omar Abdel-Wahab | Jacob D. Jaffe | Young Rock Chung | Xinyang Zhao | Jacob D Jaffe | Richard Koche | Mazhar Adli | B. Bernstein | Mazhar Adli | O. Abdel-Wahab | A. Melnick | M. Carroll | R. Koche | R. Levine | A. Shih | S. Nimer | J. Jaffe | I. Aifantis | Xinyang Zhao | Christopher Y. Park | Jay P. Patel | F. Perna | Jordan E. Taylor | Suveg Pandey | Y. R. Chung | Todd Hricik | Alan H Shih | Ross L Levine | Ari Melnick | Jie Gao | Stephen D Nimer | Martin Carroll | Todd Hricik | Lindsay M. LaFave | Jordan E Taylor | Bradley E Bernstein | Fabiana Perna | Lindsay M LaFave | Jie Gao | Suveg Pandey | Jay P Patel | Christopher Y Park | R. Levine
[1] Guy Sauvageau,et al. The Role of HOX Homeobox Genes in Normal and Leukemic Hematopoiesis , 1996, Stem cells.
[2] A. Burnett,et al. Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells , 1997, The Journal of experimental medicine.
[3] Unnur Thorsteinsdottir,et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.
[4] M. Kyba,et al. The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. , 1998, Development.
[5] V Vécsei,et al. Fatigue strength of locking screws and prototypes used in small-diameter tibial nails: a biomechanical study. , 1999, The Journal of trauma.
[6] Y. Shounan,et al. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. , 1999, Blood.
[7] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[8] Harvey F Lodish,et al. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. , 2003, Blood.
[9] T. Jacks,et al. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] Dieter Huesken,et al. Design of a genome-wide siRNA library using an artificial neural network , 2005, Nature Biotechnology.
[11] S. Lowe,et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.
[12] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[13] S. Um,et al. Additional Sex Comb-like 1 (ASXL1), in Cooperation with SRC-1, Acts as a Ligand-dependent Coactivator for Retinoic Acid Receptor* , 2006, Journal of Biological Chemistry.
[14] T. Jacks,et al. Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo. , 2006, Blood.
[15] M. Cleary,et al. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.
[16] J. Neefjes,et al. The Journal of Cell Biology , 2002 .
[17] C. Goolsby,et al. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. , 2006, Cancer research.
[18] T. Mikkelsen,et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.
[19] Kenny Q. Ye,et al. An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation , 2008, PloS one.
[20] Andrew J. Bannister,et al. JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin , 2009, Nature.
[21] Baolin Wu,et al. A role for MEIS1 in MLL-fusion gene leukemia. , 2009, Blood.
[22] S. Orkin,et al. Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells , 2009, Cell.
[23] Daniel Birnbaum,et al. Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia , 2009, British journal of haematology.
[24] Arend Sidow,et al. Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells , 2009, Cell.
[25] S. Um,et al. ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1* , 2009, The Journal of Biological Chemistry.
[26] Kristian Helin,et al. Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.
[27] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[28] S. Yoon,et al. Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor γ* , 2010, The Journal of Biological Chemistry.
[29] Juri Rappsilber,et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells , 2010, Nature.
[30] M. Wilm,et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB , 2010, Nature.
[31] Joshua F. McMichael,et al. DNMT3A mutations in acute myeloid leukemia. , 2010, The New England journal of medicine.
[32] J. Hess,et al. Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice. , 2010, Developmental biology.
[33] Ryan D. Morin,et al. Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin , 2010, Nature Genetics.
[34] Luca Mazzarella,et al. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators , 2010, Nature Cell Biology.
[35] A. Bowcock,et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.
[36] O. Abdel-Wahab,et al. Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis. , 2010, Blood.
[37] R. Kuiper,et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes , 2010, Nature Genetics.
[38] Guy Sauvageau,et al. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. , 2010, Cell stem cell.
[39] H. Drexler,et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.
[40] Jiaying Tan,et al. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. , 2010, Cancer cell.
[41] J. Hess,et al. Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. , 2010, Blood.
[42] L. Vissers,et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome , 2011, Nature Genetics.
[43] C. Sander,et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma , 2011, Nature Genetics.
[44] D. Reinberg,et al. The Polycomb complex PRC2 and its mark in life , 2011, Nature.
[45] Jacob D. Jaffe,et al. Plasticity in patterns of histone modifications and chromosomal proteins in Drosophila heterochromatin. , 2011, Genome research.
[46] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[47] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[48] M. Caligiuri,et al. ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. , 2011, Blood.
[49] D. Gilliland,et al. Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms , 2010, Leukemia.
[50] J. Becker,et al. Germline mutations in BAP1 predispose to melanocytic tumors , 2011, Nature Genetics.
[51] C. Schumann,et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] N. Cox,et al. Germline BAP1 mutations predispose to malignant mesothelioma , 2011, Nature Genetics.
[53] S. González,et al. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease , 2012, Nature Communications.
[54] L. Aravind,et al. The HARE-HTH and associated domains , 2012, Cell cycle.
[55] Bob Löwenberg,et al. Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value , 2012, Haematologica.
[56] K. Döhner,et al. Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms. , 2012, Blood.
[57] G. Boucher,et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. , 2012, Genes & development.